SCHEMBL4254059

SCHEMBL4254059

NC(=O)c1oc2cc(Cl)ccc2c1NC(=O)C1CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.61
ALDH1A1 P00352 7/20 0.61
HTT P42858 3/20 0.61
TSHR P16473 3/20 0.61
KMT2A Q03164 6/20 0.49
MEN1 O00255 5/20 0.49
GAA P10253 2/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
POLB P06746 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 3/20 0.44
TEAD1 P28347 1/20 0.44
YAP1 P46937 1/20 0.44
TEAD4 Q15561 1/20 0.44
TEAD2 Q15562 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4252530 0.90 KDM4E (0.69) KDM4EALDH1A1HTTTSHRKMT2A
SCHEMBL13699843 0.85 TSHR (0.61) KDM4EALDH1A1HTTTSHRKMT2A
SCHEMBL13699846 0.85 KDM4E (0.61) KDM4EALDH1A1HTTTSHRKMT2A
SCHEMBL13699845 0.80 KDM4E (0.57) KDM4EALDH1A1HTTTSHRKMT2A
SCHEMBL13699712 0.80 ALDH1A1 (0.60) KDM4EALDH1A1TSHRKMT2AMEN1
SCHEMBL4255835 0.78 KDM4E (0.61) KDM4EALDH1A1HTTTSHRKMT2A
SCHEMBL13699847 0.76 KDM4E (0.53) KDM4EALDH1A1HTTTSHRKMT2A
SCHEMBL13699818 0.75 KDM4E (0.55) KDM4EALDH1A1HTTTSHRKMT2A
SCHEMBL13700089 0.75 KDM4E (0.52) KDM4EALDH1A1TSHRKMT2AMEN1
SCHEMBL13699691 0.75 KDM4E (0.61) KDM4EALDH1A1HTTTSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US claimed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP claimed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1710233-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885ALDH1A1 559/4885HTT 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.